ArticleSurgical endoscopy2025
Analysis of the application value and safety of emergency enteroscopy in the treatment of patients with small bowel bleeding.
Article in Surgical endoscopy, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
- Distinct clinical course and poor outcomes of small bowel bleeding in acute hematochezia: a nationwide multicenter study.Scientific reports · 2026Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
5 authors.
Funding
Abstract
backgroundTo explore the value and safety of emergency enteroscopy (EES) in the treatment of patients with small bowel bleeding (SBB), and to analyze the etiological characteristics of SBB patients.
methodsWe collected the clinical data of 157 patients who were diagnosed as SBB and underwent emergency enteroscopy in the Sixth Affiliated Hospital of Sun Yat-sen University from May 2021 to July 2023, analyzing the results of diagnosis and treatment, as well as the occurrence of complications and follow-up.
resultsA total of 157 patients (119 males and 38 females) were included in the study, aged 7-83 (44.85 ± 17.86) years, and the disease duration was 1-9 (3.20 ± 2.20) days. There were 42 patients who underwent transoral enteroscopy, 29 patients who underwent transanal enteroscopy, and 86 patients who underwent both accesses. The diagnostic rate of EES was 90.4% (142/157). The etiology of SBB was small bowel ulcer (n = 37, 23.60%), small bowel stromal tumor (n = 11, 7.00%), post-surgical anastomotic hemorrhage (n = 20, 12.70%), vascular malformations (n = 23, 14.60%), diverticulum of the small bowel (n = 29, 18.5%), and hemangioma of the small bowel (n = 22, 14.0%). The median follow-up time of SBB patients was (16.38 ± 7.97) months with a range of 8-35 months.
conclusionsEES is safe and effective for the diagnosis of SBB and endoscopic treatment. The etiology of SBB is more common with small bowel ulcers, small bowel diverticula, vascular malformations, and hemangiomas.
Indexed as
Identifiers
40935938What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.